- \n
- 2022 update to the important guidance document for company-sponsored publications features extensive input from publication professionals.<\/li>\n
- Greater inclusivity is a key feature of the updated guidelines, with information on the role of patients in publications now included.<\/li>\n<\/ul>\n
\n![\"\"](\"https:\/\/i0.wp.com\/thepublicationplan.com\/wp-content\/uploads\/2022\/09\/iStock-1212446148.jpg?resize=801%2C436&ssl=1\")
<\/p>\nThe Good Publication Practice 2022 (GPP 2022) guidelines were unveiled on 30 August, with the fourth iteration of the guidance on company-sponsored biomedical research published in Annals of Internal Medicine<\/em><\/a>. A peer reviewed manuscript presenting the main principles of the guidance, and its detailed supplement, are freely available and can be found here<\/a>.<\/p>\n
The purpose of GPP \u2013 previously updated in 2015 \u2013 is to lay out the principles for ethical publication of industry-sponsored biomedical research. New topics covered in the 2022 edition include:<\/p>\n
- \n
- the role of patients<\/a> as authors or contributors to publications, publication policies, and procedures<\/li>\n
- use of social media<\/a> for posting about peer reviewed publications<\/span><\/li>\n
- enhanced content<\/a> such as plain language summaries, video, audio, or infographics.<\/span><\/li>\n<\/ul>\n
- use of social media<\/a> for posting about peer reviewed publications<\/span><\/li>\n
- the role of patients<\/a> as authors or contributors to publications, publication policies, and procedures<\/li>\n
![\"\"](\"https:\/\/i0.wp.com\/thepublicationplan.com\/wp-content\/uploads\/2021\/05\/Byline_Daniel-Binks.png?resize=618%2C75&ssl=1\")
<\/a><\/p>\n